spacer
The Healthcare Sales & Marketing Network celebrates 21 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare News Roundup: Biopharmaceuticals

 HSMN NewsFeed - 22 Aug 2019
Torque Expands Leadership Team with Appointment of Sok Cheng Soh as CFO and Ana Radeljevic as VP, Head of Business Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Aug 2019
Erasca Announces Key Leadership Team Appointments and Recruits World-Class Research and Development Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Aug 2019
Biofourmis Names Two Pharmaceutical Veterans to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Aug 2019
Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal(R) Nasal Spray
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 21 Aug 2019
Vanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketing Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2019
Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Aug 2019
Richter Launched Terrosa(R), its Biosimilar Teriparatide Across Europe
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 19 Aug 2019
Vanda Pharmaceuticals FDA Update for HETLIOZ(R) in the Treatment of Jet Lag Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Aug 2019
Harmony Biosciences Announces FDA Approval of WAKIX(R) (Pitolisant), a First-in-Class Medication for the Treatment of Excessive Daytime Sleepiness in Adult Patients with Narcolepsy
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Aug 2019
Mallinckrodt Announces Positive Top-Line Results from its Pivotal Phase 3 CONFIRM Trial of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1)
Biopharmaceuticals
 HSMN NewsFeed - 14 Aug 2019
Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Aug 2019
Lilly Launches Open Innovation Challenge to Help Transform Inflammatory Bowel Disease (IBD) Care through Digital Health
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 13 Aug 2019
FDA Approves EYLEA(R) (aflibercept) Injection Prefilled Syringe
Biopharmaceuticals Drug Delivery Ophthalmology FDA
 HSMN NewsFeed - 12 Aug 2019
Daiichi Sankyo, Inc. Appoints Simon King as Chief People Officer across U.S. Divisions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2019
Oncologie, Inc. Announces Clinical Trial Collaboration With Merck to Evaluate Bavituximab in Combination With KEYTRUDA(R) (Pembrolizumab) in Advanced Gastric or Gastroesophageal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Aug 2019
CASI Pharmaceuticals Announces Launch of EVOMELA(R) (melphalan for injection) in China
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 7 Aug 2019
Glycomine, Inc. Announces $33 Million Series B Financing to Advance its Therapy for a Congenital Disease of Glycosylation
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 7 Aug 2019
Lilly Announces Leadership Changes in Corporate Business Development, Oncology R&D, and Managed Healthcare Services
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2019
Dupixent(R) (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 5 Aug 2019
AbbVie Submits New Drug Application to US FDA for Investigational Elagolix for Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Women
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Aug 2019
Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 5 Aug 2019
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) THIN LIQUID (barium sulfate) for oral suspension
Biopharmaceuticals Radiology Gastroenterology FDA
 HSMN NewsFeed - 5 Aug 2019
Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Aug 2019
Lilly Announces Positive Results for Emgality(R) (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Aug 2019
Axon Neuroscience Appoints Michal Fresser as Group CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Aug 2019
InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2019
Endo Applauds U.S. District Court Decision that Vasopressin Cannot be Used for Compounding by Outsourcing Facilities
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Aug 2019
Endo Appoints Domenico Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo(R) (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Jul 2019
Biohaven Enrolls First Patient In Phase 3 Clinical Trial Of Verdiperstat, Oral Myeloperoxidase Inhibitor, For The Treatment Of Multiple System Atrophy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Jul 2019
REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich's Ataxia Using NAV(R) AAV9 Vector
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 31 Jul 2019
Results of the Pivotal Phase 3 Study of the Bempedoic Acid / Ezetimibe Combination Tablet Published in the European Journal of Preventative Cardiology Demonstrated Significant LDL-C Lowering
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Jul 2019
Acerus And Aytu Bioscience To Co-Promote NATESTO(R) In The United States
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Jul 2019
Lilly's Verzenio(R) (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Jul 2019
Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX(R) Platform Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Jul 2019
Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jul 2019
Statement from Mylan's Board of Directors Regarding Retirement of CEO and Board Member Heather Bresch in Conjunction with the Combination of Mylan and Upjohn, a Division of Pfizer
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 29 Jul 2019
Epygenix Therapeutics Receives IND Approval of EPX-100 for the Treatment of Dravet Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Jul 2019
Obsidian Therapeutics Announces Strengthening of Executive Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2019
U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 23 Jul 2019
Lipocine Receives FDA Clearance for Clinical Testing its NASH Candidate, LPCN 1144, in Expanded Target Population
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jul 2019
Proteostasis Therapeutics Announces Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2019
Geron Enhances Oncology Expertise to Advance Corporate Objectives
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jul 2019
Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Jul 2019
Vanda Pharmaceuticals FDA Update for HETLIOZ(R) in the Treatment of Jet Lag Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jul 2019
Halozyme Announces Janssen Submits Extension Application To European Medicines Agency For Subcutaneous Formulation Of DARZALEX(R) Utilizing ENHANZE(R) Technology
Biopharmaceuticals Oncology Drug Delivery Regulatory
 HSMN NewsFeed - 19 Jul 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jul 2019
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 18 Jul 2019
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part Of A Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2019
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Jul 2019
U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 17 Jul 2019
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 16 Jul 2019
Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases
Biopharmaceuticals Oncology Neurology
 HSMN NewsFeed - 15 Jul 2019
AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Jul 2019
Kymera Therapeutics Announces Leadership Transitions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2019
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Jul 2019
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jul 2019
Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Jul 2019
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Jul 2019
AHS 2019: Post-Hoc Analyses of Phase 3 Pivotal Studies of Emgality(R) (galcanezumab-gnlm) Show Improvements in Daily Functioning and Reductions in Disability in Patients with Chronic and Episodic Migraine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Jul 2019
New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality(R) (galcanezumab-gnlm) in Episodic Cluster Headache
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Jul 2019
BioMarin Appoints Pharmaceutical Veteran and Former J & J Executive, Liz McKee Anderson, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2019
IDEAYA Biosciences Strengthens Management with Internal Appointments of Paul Stone, J.D., as Chief Financial Officer, Andres Ruiz Briseno, C.P.A., as Vice President, Finance, and Mick O'Quigley, M.B.A, as Vice President, Development Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jul 2019
Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Jul 2019
Skyhawk Therapeutics Announces Addition of World Leading SAB Head & New VP of Oncology Biology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jul 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2019
Lannett Enters Into Distribution Agreement For Levothyroxine
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 3 Jul 2019
Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2019
InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2019
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2019
Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Jun 2019
Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch
Biopharmaceuticals Generics Distribution Product Launch
 HSMN NewsFeed - 28 Jun 2019
BioAtla Appoints Eric Sievers, M.D., As Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Biopharmaceuticals Regulatory
Older Biopharmaceuticals stories   Return to NewsFeed  
FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.